Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract

World Journal of Urology

Volumn 23, Issue 6, 2005, Pages 368-373

  Ückert, Stefan ^a,b   Stief, Christian G ^c   Mayer, Margit ^c   Jonas, Udo ^a   Hedlund, Petter ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IPF PHARMACEUTICALS GMBH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Lower urinary tract; Phosphodiesterase isoenzymes

Indexed keywords

ISOENZYME; PHOSPHODIESTERASE;

ARTICLE; BLADDER; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; PHYSIOLOGY; PROSTATE; URETER; URETHRA;

HUMANS; ISOENZYMES; MALE; PHOSPHORIC DIESTER HYDROLASES; PROSTATE; URETER; URETHRA; URINARY BLADDER;

EID: 31144474092     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00345-005-0017-3     Document Type: Article

References (41)

1. Schmidt HW, Lohmann SM, Walter U (1993) The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1178:153-175 10.1016/0167-4889(93)90006-B
2. Pozzan T, Rizutto R, Volpe P, Meldolesi J (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 74:595-636 8036248
3. Michaeli T, Bloom TJ, Martins T, Loughney K, Ferguson K, Riggs M, Rodgers L, Beavo JA, Wigler M (1994) Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase deficient Saccharomyces cerevisiae. J Biol Chem 268:12925-12932
4. Han P, Zhu X, Michaeli T (1997) Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem 272:16152-16157 10.1074/jbc.272.26.16152
5. Fisher AD, Smith JF, Pillar JS, St. Denis S, Cheng JB (1998) Isolation and characterization of PDE8A, a novel cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 246:570-577 10.1006/bbrc.1998.8684
6. Fisher AD, Smith JF, Pillar JS, St. Denis S, Cheng JB (1998) Isolation and characterization of PDE9A, a novel cGMP-specific phosphodiesterase. J Biol Chem 273:15559-15564 10.1074/jbc.273.25.15559
7. Loughney K, Snyder PB, Uher L, Rosman GJ, Ferguson K, Florio VA (1999) Isolation and characterization of PDE10A, a novel human 3′,5′-cyclic nucleotide phosphodiesterase. Gene 234:109-117 10.1016/S0378-1119(99)00171-7
8. Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA, Philips SC (2000) Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 97:3702-3707 10.1073/pnas.050585197
9. Conti M, Jin SL (1999) The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 63:1-38 10506827
10. Soderling SH, Beavo JA (2000) Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions. Curr Opin Cell Biol 12:174-179 10.1016/S0955-0674(99)00073-3
11. Wheeler MA, Ayyagari RR, Wheeler GL, Weiss RM (2005) Regulation of cyclic nucleotides in the urinary tract. J Smooth Muscle Res 41:1-21 10.1540/jsmr.41.1
12. Andersson KE, Chapple C, Wein A (2001) The basis for drug treatment of the overactive bladder. World J Urol 19:294-298 11760776
13. Sellers DJ, Chapple CR, Chess-Williams R (2001) Potential therapeutic targets for the treatment of the overactive bladder. World J Urol 19:307-311 11760778
14. Truss MC, Ückert S, Stief CG, Kuczyk MA, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle: I. Identification and characterization. Urol Res 24:123-128 10.1007/BF00304074
15. Stacey P, Rulten S, Dapling A, Phillips SC (1998) Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247:249-254 10.1006/bbrc.1998.8769
16. Morley DJ, Hawley DM, Ulbright TM, Butler LG, Culp JS, Hodes ME (1987) Distribution of phosphodiesterase I in normal human tissues. J Histochem Cytochem 35:75-82 3025290
17. Truss MC, Ückert S, Stief CG, Kuczyk MA, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle: II. Effect of various PDE-inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res 24:129-134 10.1007/ BF00304075
18. Ückert S, Seemann C, Stief CG, Lietz B, Neuhaus L, Bischoff E, Jonas U (2002) Funktionelle In vitro-Effekte cAMP/cGMP-modulierender Pharmaka am humanen Detrusormuskel. J Urol Urogynäkol 1:7-14
19. Truss MC, Stief CG, Ückert S, Becker AJ, Wefer J, Schultheiss D, Jonas U (2001) Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside. World J Urol 19:344-350 10.1007/s003450100221
20. Taher A, Schulz-Knappe P, Meyer M, Truss MC, Forssmann WG, Stief CG, Jonas U (1994) Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol 12:286-291 10.1007/BF00191209
21. Kühn R, Ückert S, Stief CG, Truss MC, Lietz B, Bischoff E, Schramm M, Jonas U (2000) Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide dependent pathways Urol Res 28 110-115 10.1007/s002400050147
22. Saighi D, Zerbib M, Thiounn N, Flam T, Conquy S, Jacob L, Dall'Ava-Santucci J, Debre B, Dinh-Xuan AT (2000) In vitro study of the modulation of human ureteral tonus by nitric oxide and zaprinast, a phosphodiesterase inhibitor. Prog Urol 10:1161-1168 11217553
23. Becker AJ, Stief CG, Meyer M, Truss MC, Forssmann WG, Jonas U (1998) The effect of the specific phosphodiesterase 4 inhibitor rolipram on the ureteral peristalsis in vitro and in vivo. J Urol 160:920-925 10.1097/ 00005392-199809010-00089
24. Kuciel R, Ostrowski W (1970) Phosphodiesterase from human prostate gland. Bull Soc Chim Biol (Paris) 52:1051-1060
25. Mennella MR, Jones MR (1977) The activity of some nucleolytic enzymes in semen and in the secretion of the male reproductive tract. Andrologia 9:15-22 193415
26. Drescher P, Eckert RE, Madsen PO (1994) Smooth muscle contractility in prostatic hyperplasia: Role of cyclic adenosine monophosphate. Prostate 25:76-80 7518597
27. Takeda M, Tang R, Shapiro E, Burnett AL, Lepor H (1995) Effects of nitric oxide on human and canine prostates. Urology 45:440-446 10.1016/ S0090-4295(99)80013-2
28. Bloch W, Klotz T, Loch C, Schmidt G, Engelmann U, Addicks K (1997) Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate 33:1-8 10.1002/ (SICI)1097-0045(19970915)33:1<1::AID-PROS1>3.0.CO;2-P
29. Ückert S, Küthe A, Jonas U, Stief CG (2001) Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166:2484-2490 10.1097/ 00005392-200112000-00127
30. Rentero C, Monfort M, Puigdomenech P (2003) Identification and distribution of different mRNA variants produced by different splicing in the human phosphodiesterase 9A gene. Biochem Biophys Res Commun 301:686-692 10.1016/S0006-291X(03)00021-4
31. Ückert S, Hedlund P, Stief CG, Andersson KE, Jonas U (2003) Histochemische Distribution cAMP- und cGMP-spezifischer Phosphodiesterase-Isoenzyme in der humanen Prostata. Wiener Klin Wochenschr 115(Heft 11, Suppl 1):18 (Abstract)
32. Hopps CV, Mulhall JP (2003) Assessment of the impact of sildenafil citrate on lower urinary tract symptoms (LUTS in men with erectile dysfunction). J Urol 169(Suppl 4):375 (Abstract)
33. Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA, Phillips SC (2000) Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 97:3702-3707 10.1073/pnas.050585197
34. Ückert S, Hedlund P, Oelke M, Stief CG, Andersson KE, Jonas U (2004) Immunohistochemical presence of phosphodiesterase 11A in the human prostate. J Urol 171(Suppl 4):352 (Abstract)
35. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, Whitesell L, Ha MJ, Tsokos M, Sheahan MD, Nguyen P, Niklinski WT, Myers MJ, Trepel JB (2003) Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 91:5330-5334
36. Goto T, Matsushima H, Hasuya Y, Kosaka Y, Kitamura T, Kawabe K, Hida A, Otha Y, Simizu T, Takeda K (1999) The effect of papaverine on morphologic differentiation, proliferation and invasive potential of human prostatic cancer LNCaP cells. Int J Urol 6:314-319 10.1046/ j.1442-2042.1999.00069.x
37. Liu L, Li H, Underwood T, Lloyd M, David M, Sperl G, Pamukcu R, Thompson WJ (2001) Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J Pharmacol Exp Ther 299:583-592 11602670
38. Soh JW, Mao Y, Kim MG, Pamukcu R, Li H, Piazza GA, Thompson WJ, Weinstein IB, (2000) Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-JunNH 2 -terminal kinase 1. Clin Cancer Res 6:4136-4141 11051267
39. Morita T, Ando M, Kihara K, Kitahara S, Ishizaka K, Matsumura T, Oshima H (1994) Effects of prostaglandins E1, E2 and F2 alpha on contractility and cAMP and cGMP contents in lower urinary tract smooth muscle. Urol Int 52:200-203 8030166
40. Dokita S (1989) Functional roles of cyclic AMP and cyclic GMP on rabbit urinary bladder and urethral smooth muscle contraction Nippon. Hinyokika Gakkai Zasshi 80:1343-1350 2556606
41. Werkstrom V, Persson K, Ny L, Bridgewater M, Brading AF, Andersson KE (1995) Factors involved in the relaxation of female pig urethra evoked by electrical field stimulation. Br J Pharmacol 116:1599-1604 8564225